课题基金 / 基金详情

T cell immunity to influenza virus in the aged nasal mucosa

T cell immunity to influenza virus in the aged nasal mucosa
老化鼻粘膜中T细胞对流感病毒的免疫
批准号:
8520147
负责人:
Bas Baaten
金额:
$37.78万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2016-05-31

项目摘要

项目成果

Bas Baaten的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):拟议研究的目的是阐明流感病毒感染后老年人鼻相关淋巴组织(NALT)中CD8 T细胞反应降低的原因。流感病毒具有很强的传染性,每年平均造成3.6万人死亡,22.6万人住院。老年人尤其容易受到流感的威胁,流感是第五大死因。随着年龄的增长,免疫反应的逐渐下降与老年人接种疫苗的效力降低有关。此外,新的流感病毒株的不断出现缩短了免疫提供保护的有效期限。由保守的病毒成分生成的T细胞在解决流感病毒感染中至关重要,可以防止抗原性不同的挑战,它们在老年人中的存在与疫苗效力高度相关。因此,模拟自然感染并诱导T细胞对保守表位(如冷适应减毒流感病毒(LAIV))的反应的疫苗策略将是有利的。然而,由于缺乏研究,市售的LAIV“Flumist”尚未获得老年人的许可。LAIV通过鼻黏膜给药,仅在上呼吸道复制,NALT可能在诱导免疫应答中起关键作用。对于鼻腔接种疫苗或感染后的免疫事件知之甚少。我们在初步研究中表明,老年人实验性LAIV免疫可导致NALT中T细胞反应受损。我们假设NALT的粘膜环境对流感病毒免疫至关重要,但随着年龄的变化会影响CD8 T细胞免疫反应的能力。老年NALT中T细胞数量的减少可能有以下几个原因:鼻腔dc诱导CD8 T细胞的能力下降,NALT环境的变化,老年CD4 T细胞对CD8 T细胞的帮助不足,或老年CD8 T细胞迁移到鼻黏膜的能力改变。我们的目标是阐明NALT对LAIV的诱导T细胞效应反应。我们将确定树突状细胞如何以及哪些细胞诱导CD8 T细胞,以及NALT环境如何影响CD8 T细胞免疫。此外,我们将确定CD8 T细胞进入NALT所需的趋化因子和粘附受体表达谱,CD4 T细胞所需的帮助水平,以及两者如何随年龄而受影响。拟议的研究对于理解老年人鼻内接种疫苗或自然感染后NALT中CD8 T细胞免疫如何产生的机制至关重要。此外,它们将为NALT中的“正常”免疫反应提供重要见解,即(记忆)T细胞如何在体内循环,作为其监视功能的一部分。老年NALT感染后免疫事件的新发现可能导致确定改进老年人呼吸道病毒疫苗的策略,老年人是发达国家人口中增长最快的部分。
英文摘要
DESCRIPTION (provided by applicant): The aim of the proposed research is to elucidate the reason(s) for reduced CD8 T cell responses in the nasal- associated lymphoid tissue (NALT) of the aged following influenza virus infection. Influenza viruses are very contagious and cause an average of 36,000 deaths and 226,000 hospitalizations in yearly epidemics. The elderly particularly are at risk with influenza ranking as the fifth leading cause of death. A progressive decline in the immune response with aging is associated with reduced efficacy of vaccination in the elderly. In addition, the continuous emergence of new influenza virus strains reduces the effective period of the protection provided by immunization. T cells generated to conserved viral components are crucial in resolving influenza virus infection, can protect from antigenically disparate challenges, and their presence in the elderly is highly correlated with vaccine efficacy. Thus, vaccine strategies that mimic natural infection and induce T cell responses to conserved epitopes, such as cold-adapted live attenuated influenza virus (LAIV), would be advantageous. However, the commercially available LAIV 'Flumist' is not licensed in the elderly, due to a lack of studies. LAIV is administered via the nasal mucosa and replicates only in the upper respiratory tract, and the NALT could play a crucial role in the induction of immune response. Little is known about the immunological events following either nasal vaccination or infection. We show in preliminary studies that experimental LAIV immunization of the aged results in impaired T cell responses in the NALT. We hypothesize that the mucosal environment of the NALT is crucial for influenza virus immunity, but that changes with age affect the ability to mount an appropriate CD8 T cell immune response. The decrease in T cell number in aged NALT could have several reasons: reduced capability of nasal DCs to induce CD8 T cells, changes in the NALT environment, deficiencies in aged CD4 T cell help to CD8 T cells, or changes in the aged CD8 T cells' capability to migrate into the nasal mucosa. Our goals are to elucidate the induction of the T cell effector response in the NALT in response to LAIV. We will determine how and what dendritic cells induce CD8 T cells and how the NALT environment affects CD8 T cell immunity. Furthermore, we will identify the chemokine and adhesion receptor expression profile required for CD8 T cell entry into the NALT, the level of CD4 T cell help needed, and how both are affected with age. The proposed studies are crucial towards understanding the mechanism(s) of how CD8 T cell immunity is generated in the NALT following intranasal vaccination or natural infection in the aged. In addition, they will provide important insights into the 'normal' immune response in the NALT, i.e. how do (memory) T cells circulate through the body as part of their surveillance function. Novel findings into the immunological events in the aged NALT after infection could lead to the identification of strategies for improvement of vaccines to respiratory viruses for the elderly, which are the fastest growing segment of the population in developed countries.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Imprinting of nasal Th2 cell trafficking during allergic sensitization
T cell immunity to influenza virus in the aged nasal mucosa
T cell immunity to influenza virus in the aged nasal mucosa
T cell immunity to influenza virus in the aged nasal mucosa
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: